Mayo Clinic researchers have developed a new method to identify which proteins are most likely to trigger an immune response—a discovery that could help improve transplant care, regenerative medicine and other areas where the immune system plays a critical role. The results, published in Biomaterials, challenge a common assumption in the field that all proteins are equally likely to provoke immune reactions.
Continue Reading this article here
